Table 3.
Lung Donor and Recipient Characteristics
| Donation after Circulatory Determination of Death (DCDD) |
Donation after Neurologic Determination of Death (DNDD) |
Percent missing | |
|---|---|---|---|
| Donor Characteristics | n = 162 (1.3%) | n = 12495 (98.7%) | |
| Age | 37.5 (25.25, 47) | 31 (21, 46) | 0% |
| Male (%) | 97 (60%) | 7386 (59%) | 0% |
| Race | 0% | ||
| White (%) | 139 (86%) | 7631 (61%) | |
| Black (%) | 9 (6%) | 2504 (20%) | |
| Asian/Pacific Islander (%) | 3 (2%) | 359 (3%) | |
| Hispanic (%) | 10 (6%) | 1931 (15%) | |
| Other (%) | 1 (1%) | 70 (1%) | |
| Body Mass Index | 25.14 (22.67, 28.93) | 24.82 (22.03, 28.26) | 0% |
| Cigarette Use > 20 pack years (%) | 13 (8%) | 1283 (10%) | 1% |
| Increased Risk Donor (%) | 8 (5%) | 1033 (8%) | 0% |
| WLST to Death Time (min)* | 21 (16, 29) | NA | 14% |
| WLST to Cannulation Time (min)* | 26.5 (22.8, 33.0) | NA | 75% |
| Chest Radiograph | 0% | ||
| No Chest X-ray (%) | 4 (2%) | 80 (1%) | |
| Normal (%) | 90 (56%) | 6284 (50%) | |
| Abnormal (%) | 66 (42%) | 6032 (48%) | |
| Bronchoscopy | |||
| Left Lung | 5% | ||
| No Bronchoscopy (%) | 48 (31%) | 594 (5%) | |
| Normal (%) | 89 (57%) | 9147 (77%) | |
| Purulent Secretions (%) | 10 (6%) | 1211 (10%) | |
| Right Lung | 7% | ||
| No Bronchoscopy (%) | 47 (32%) | 580 (5%) | |
| Normal (%) | 85 (57%) | 8587 (74%) | |
| Purulent Secretions (%) | 7 (5%) | 1402 (12%) | |
| PaO2 ≥ 300 mmHg on 100% FiO2 (%) | 109 (69%) | 8924 (72%) | 1% |
| PaO2 on 100% FiO2 | 398 (196.5, 480.5) | 420 (247, 492) | 1% |
| Recipient Characteristics | n = 169 | n = 13,394 | |
| Age | 58 (44, 63) | 58 (47, 64) | 0% |
| Male (%) | 106 (63%) | 7866 (59%) | 0% |
| LAS Primary Diagnosis Group (%) | 0% | ||
| A (Obstructive Lung Disease) | 46 (27%) | 3933 (29%) | |
| B (Pulmonary Vascular Disease) | 8 (5%) | 466 (3%) | |
| C (Cystic Fibrosis) | 30 (18%) | 1760 (13%) | |
| D (Restrictive Lung Disease) | 84 (50%) | 7202 (54%) | |
| Other | 1 (1%) | 33 (0%) | |
| Cold Ischemia Time | 317 (257.5, 410.5) | 301 (244, 350.5) | 98% |
| Pre-Transplant Medical Condition | 1% | ||
| Hospitalized in ICU (%) | 23 (14%) | 1293 (10%) | |
| Hospitalized not in ICU (%) | 19 (12%) | 1175 (9%) | |
| Not Hospitalized (%) | 122 (74%) | 10728 (81%) | |
| Extracorporeal Membrane Oxygenation (%) | 11 (7%) | 269 (2%) | 0% |
| Mechanical Ventilation (%) | 17 (10%) | 1035 (8%) | 0% |
| LAS | 0% | ||
| At Listing | 36.27 (33.55, 42.94) | 37.01 (33.48, 44.12) | |
| At Transplant | 39.57 (34.47, 52.12) | 39.89 (34.71, 50.69) |
*
WLST refers to withdrawal of life-sustaining treatment